NCT06028828View on ClinicalTrials.gov

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions
Allogeneic Hematopoietic Stem Cell TransplantationAllogeneic Stem Cell TransplantationHematologic Malignancies
Interventions
DRUG

Fludarabine

Given Day-5, Day-4, Day-3, Day-2

DRUG

Melphalan

Given Day-5

RADIATION

Total Body Irradiation

Given Day-1

Trial Locations (1)

92868

RECRUITING

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER